State Street’s Aldeyra Therapeutics ALDX Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $4.05M | Buy |
1,056,585
+35,204
| +3% | +$135K | ﹤0.01% | 3034 |
|
2025
Q1 | $5.87M | Sell |
1,021,381
-11,992
| -1% | -$69K | ﹤0.01% | 2812 |
|
2024
Q4 | $5.16M | Buy |
1,033,373
+59,465
| +6% | +$297K | ﹤0.01% | 2958 |
|
2024
Q3 | $5.25M | Buy |
973,908
+16,188
| +2% | +$87.3K | ﹤0.01% | 2951 |
|
2024
Q2 | $3.17M | Buy |
957,720
+18,151
| +2% | +$60.1K | ﹤0.01% | 3119 |
|
2024
Q1 | $3.07M | Buy |
939,569
+40,560
| +5% | +$133K | ﹤0.01% | 3123 |
|
2023
Q4 | $3.16M | Sell |
899,009
-2,166,958
| -71% | -$7.61M | ﹤0.01% | 3153 |
|
2023
Q3 | $20.5M | Buy |
3,065,967
+24,101
| +0.8% | +$161K | ﹤0.01% | 2167 |
|
2023
Q2 | $25.5M | Buy |
3,041,866
+2,868,585
| +1,655% | +$24.1M | ﹤0.01% | 2089 |
|
2023
Q1 | $1.72M | Hold |
173,281
| – | – | ﹤0.01% | 3386 |
|
2022
Q4 | $1.21M | Sell |
173,281
-600
| -0.3% | -$4.18K | ﹤0.01% | 3519 |
|
2022
Q3 | $929K | Hold |
173,881
| – | – | ﹤0.01% | 3611 |
|
2022
Q2 | $694K | Sell |
173,881
-703,916
| -80% | -$2.81M | ﹤0.01% | 3718 |
|
2022
Q1 | $3.9M | Sell |
877,797
-2,204,555
| -72% | -$9.8M | ﹤0.01% | 3300 |
|
2021
Q4 | $12.3M | Sell |
3,082,352
-345,027
| -10% | -$1.38M | ﹤0.01% | 2792 |
|
2021
Q3 | $30.1M | Buy |
3,427,379
+294,240
| +9% | +$2.58M | ﹤0.01% | 2180 |
|
2021
Q2 | $35.5M | Buy |
3,133,139
+710,115
| +29% | +$8.05M | ﹤0.01% | 2104 |
|
2021
Q1 | $28.8M | Buy |
2,423,024
+2,402,324
| +11,605% | +$28.5M | ﹤0.01% | 2128 |
|
2020
Q4 | $142K | Buy |
20,700
+1,600
| +8% | +$11K | ﹤0.01% | 3787 |
|
2020
Q3 | $142K | Hold |
19,100
| – | – | ﹤0.01% | 3687 |
|
2020
Q2 | $80K | Sell |
19,100
-383,909
| -95% | -$1.61M | ﹤0.01% | 3672 |
|
2020
Q1 | $995K | Sell |
403,009
-14,198
| -3% | -$35.1K | ﹤0.01% | 3308 |
|
2019
Q4 | $2.42M | Buy |
417,207
+18,351
| +5% | +$107K | ﹤0.01% | 3186 |
|
2019
Q3 | $2.1M | Sell |
398,856
-352
| -0.1% | -$1.86K | ﹤0.01% | 3199 |
|
2019
Q2 | $2.4M | Buy |
399,208
+44,006
| +12% | +$264K | ﹤0.01% | 3170 |
|
2019
Q1 | $3.21M | Buy |
355,202
+70,722
| +25% | +$639K | ﹤0.01% | 2967 |
|
2018
Q4 | $2.36M | Buy |
284,480
+37,690
| +15% | +$313K | ﹤0.01% | 3055 |
|
2018
Q3 | $3.41M | Buy |
246,790
+10,164
| +4% | +$140K | ﹤0.01% | 3046 |
|
2018
Q2 | $1.88M | Buy |
236,626
+210,695
| +813% | +$1.67M | ﹤0.01% | 3291 |
|
2018
Q1 | $194K | Buy |
25,931
+3,262
| +14% | +$24.4K | ﹤0.01% | 3560 |
|
2017
Q4 | $155K | Buy |
22,669
+4,169
| +23% | +$28.5K | ﹤0.01% | 3585 |
|
2017
Q3 | $133K | Buy |
+18,500
| New | +$133K | ﹤0.01% | 3624 |
|